RUNX2 and osteosarcoma: However, further validation is needed to determine whether the increased osteogenic differentiation in osteosarcoma cells resulting from ITGB3-KD-mediated activation of the JNK/c-JUN/RUNX2 pathway directly regulates apoptosis in osteosarcoma cells.